logo
Share SHARE
FONT-SIZE Plus   Neg

FDA Accepts Actelion's NDA For Macitentan

Actelion Pharmaceuticals Ltd. (ALIOF.PK, ATLN.L) Friday said its New Drug Application, or NDA, for macitentan has been accepted by The U.S. Food and Drug Administration.

Macitentan is registered under the name Opsumit, and is used for the treatment of patients with pulmonary arterial hypertension.

Pulmonary arterial hypertension is a chronic disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs of an affected individual.

In a random, pivotal, long-term Phase III study, Macitentan was found to reduce the risk of morbidity and mortality event over the treatment period versus placebo.

For patients in the 10 mg and 3 mg dose group, risk was reduced by 45 percent and 30 percent, respectively. Meanwhile, nasopharyngitis, headache and anemia were the most common adverse events associated with the use of macitentan.

The review period is expected to last 12 months from the date of NDA submission.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
New York's landmark Waldorf Astoria hotel will be shut for up to three years starting spring 2017 as its Chinese owner Anbang Insurance Group Co. plans to convert most of its 1,413 hotel rooms into luxury condominiums, according to media reports. Starbucks Corp., for the first time, will offer a single-origin coffee from India to customers in the U.S. under an expansion of the specialty coffee retailer's joint venture partnership with Indian conglomerate Tata Group. Starbucks customers in the U.S. will be able to experience a rare, small-lot coffee from the Tata Nullore Estates located in the Coorg region of India. For the Independence Day week-end, starting June 30, travel volume will be a record this year, predicts the American Automobile Association or AAA. Friday and Monday afternoons are expected to be the peak hours. Cruising seems to be a favorite travel mode this year with 35 percent increase from last...
comments powered by Disqus
Follow RTT